Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I

L. V. Stamm, H. L. Bergen, K. A. Shangraw
L. V. Stamm
Program in Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. L. Bergen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. A. Shangraw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.45.10.2973-2974.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Rifampin is an antibiotic that interacts specifically with the β-subunit of DNA-dependent RNA polymerase (RpoB) encoded by therpoB gene (2). Rifampin resistance (Rifr) is usually due to changes in the amino acid sequence of the target site resulting in reduced affinity of RpoB for rifampin. The majority of Escherichia coli Rifr mutations are located in two highly conserved regions of RpoB encompassing amino acid residues 507 to 533 (Rif cluster I) and 563 to 572 (Rif cluster II) (2). Substitutions in these clusters, particularly at “hot spots” such as the residue cognate to E. coli S531, are responsible for acquired Rifr in several species of bacteria. Less common mechanisms of Rifr include mutations in RpoB outside Rif clusters I and II, decreased membrane permeability, efflux, and enzymatic modification of the antibiotic.

Several species of free-living and host-associated spirochetes of the genera Spirochaeta, Leptospira, andTreponema that were isolated without rifampin are resistant to relatively high concentrations of this antibiotic (MICs, 50 to >200 μg/ml) (5). Rifr is widespread among spirochetes, and rifampin sensitive strains have not been isolated (5, 10). Studies conducted by Leschine and Canale-Parola (5) with purified Spirochaeta aurantia RpoB suggested that spirochetal Rifr may be due to a low affinity of RpoB for rifampin. Alekshun et al. (1) proposed that an N at the RpoB residue cognate to E. coliS531 is the primary molecular determinant of naturally occurring Rifr in Borrelia burgdorferi and possibly in other spirochetes. Furthermore, Lee et al. (4) observed an N531 in the RpoB of 22 Borrelia reference strains. Our analysis of the complete amino acid sequences of Treponema pallidum strain Nichols (AE001205) and Leptospira biflexa (AF150880) RpoB confirmed the presence of an N531 in both organisms. Additional amino acid substitutions associated with Rifr were not present inside or outside Rif clusters I and II. These observations prompted us to examine the Rif clusters of several Rifr host-associated Treponema spp.

Treponema pallidum Street strain 14, an erythromycin-resistant clinical isolate, was grown by testicular cultivation in rabbits as previously described (8).T. denticola (ATCC 35405) and T. phagedenis(Reiter) were grown as previously described (7). T. socranskii subsp. socranskii (ATCC 35536) and T. medium G7201 were grown in NOS medium as previously described (6). Four clonal isolates of bovine papillomatous digital dermatitis (PDD)-associated Treponema were grown as previously described (9). Genomic DNA was extracted from each of the Treponema spp. as previously described (8). The complete rpoB of T. pallidum Street strain 14 was PCR amplified using primers (forward, 5′-CGGCGTCTCCCCTGTGTG-3′; reverse, 5′-ATTGTCTCAGGCTTTTTCAC-3′) based on Nichols strain nucleotide sequences flanking rpoB (AE001205). An approximately 2.3-kb internal fragment of rpoB was amplified from each of the cultivable Treponema spp. using PCR primers (forward, 5′-CGTTCGCCTGGTGTTATC-3′; reverse, 5′-AGACCCTTGTTTCCGTGG-3′) based on the preliminary sequence of T. denticola rpoB (The Institute for Genomic Research,http: //www.tigr.org). Gel-purified PCR amplicons were cloned and both DNA strands were sequenced as previously described (8).

A deduced amino acid sequence alignment representing the RpoB region containing Rif clusters I and II for each of the Treponemaspp. is presented in Fig. 1. The corresponding sequences of rifampin-sensitive E. coli andStaphylococcus aureus and RifrL. biflexa and B. burgdorferi are shown for comparison. Although substitutions in Rif cluster I residues 508, 518, and 531 are present in all of the Treponema spp., only the N531 substitution correlates with Rifr. While not commonly observed in Rifr bacteria, an N531 substitution is associated with high-level resistance in Mycobacterium celatum, an organism that is naturally Rifr(3). Substitutions in Rif cluster II are not present in any of the Treponema spp.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Deduced amino acid sequence alignment ofTreponema spp. RpoB region containing Rif clusters I and II with the corresponding sequences of wild-type rifampin-sensitiveE. coli (AE000472) and S. aureus (X64172) and naturally RifrL. biflexa (AF150880) andB. burgdorferi (L48488). Numbering is based on the E. coli RpoB sequence. Rif clusters I and II are indicated. Residues where amino acid substitutions are known to correlate with Rifr are boldfaced. Arrow, N531 substitution that is present in all Treponema spp. and correlates with Rifr. Abbreviations: Eco, E. coli;Sau, S. aureus, Lbi, L. biflexa; Bbu, B. burgdorferi;Tpa, T. pallidum Street strain 14;Tde, T. denticola 35405; Tme, T. medium G7201; Tso, T. socranskii subsp.socranskii; Tph, T. phagedenis Reiter; PDD1, PDD-associated Treponema isolate 1-9185MED; PDD2, isolate 9-3379; PDD3, isolate 7-2009; PDD4, isolate 2-1498. The amino acid sequence of T. pallidum Street strain 14 is identical to that of T. pallidum strain Nichols (AE001205) in the RpoB region shown.

Our results support the hypothesis of Alekshun et al. (1) that N531 is primarily responsible for spirochetal Rifr. However, some variations in the level of Rifr among cultivable spirochetes, including Treponema spp., have been reported (5, 10). It is possible that additional mechanisms such as membrane permeability or mutations occurring in RpoB outside Rif clusters I and II are responsible for such observations. Further studies are required to elucidate this. Finally, our results also support the use of rifampin as a selective agent for the isolation of Treponema spp. from human and animal specimens (5).

The sequences of the 198-bp region of rpoB from theTreponema spp. have been deposited in GenBank under accession numbers AF389072 to AF389080.

ACKNOWLEDGMENTS

We thank G. Riviere for providing T. socranskii andT. medium and R. Walker for providing PDD-associatedTreponema isolates.

This research was supported by National Institutes of Health grant AI31496.

  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Alekshun M.,
    2. Kashlev M.,
    3. Schwartz I.
    Molecular cloning and characterization of Borrelia burgdorferi rpoB. Gene 186 1997 227 235
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Jin D. J.,
    2. Gross C. A.
    Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202 1988 45 58
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Kim B.-J.,
    2. Lee S.-H.,
    3. Lyu M.-A.,
    4. Kim S.-J.,
    5. Bai G.-H.,
    6. Kim S.-J.,
    7. Chae G.-T.,
    8. Kim E.-C.,
    9. Cha C.-Y.,
    10. Kook Y.-H.
    Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37 1999 1714 1720
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Lee S.-H.,
    2. Kim B.-J.,
    3. Kim J.-H.,
    4. Park K.-H.,
    5. Kim S.-J.,
    6. Kook Y.-H.
    Differentiation of Borrelia burgdorferi sensu lato on the basis of RNA polymerase gene (rpoB) sequences. J. Clin. Microbiol. 38 2000 2557 2562
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Leschine S. B.,
    2. Canale-Parola E.
    Rifampin-resistant RNA polymerase in spirochetes. FEMS Microbiol. Lett. 35 1986 199 204
    OpenUrlCrossRef
  6. 6.↵
    1. Riviere G. R.,
    2. Smith K. S.,
    3. Willis S. G.,
    4. Riviere K. H.
    Phenotypic and genotypic heterogeneity among cultivable pathogen-related oral spirochetes and Treponema vincentii. J. Clin. Microbiol. 37 1999 3676 3680
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Stamm L. V.,
    2. Gherardini F. C.,
    3. Parrish E. A.,
    4. Moomaw C. R.
    Heat shock response of spirochetes. Infect. Immun. 59 1991 1572 1575
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Stamm L. V.,
    2. Bergen H. L.
    A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob. Agents Chemother. 44 2000 806 807
    OpenUrlFREE Full Text
  9. 9.↵
    1. Walker R. L.,
    2. Read D. H.,
    3. Loretz K. J.,
    4. Nordhausen R. W.
    Spirochetes isolated from dairy cattle with papillomatous digital dermatitis and interdigital dermatitis. Vet. Microbiol. 47 1995 343 355
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Wyss C.,
    2. Choi B. K.,
    3. Schüpbach P.,
    4. Guggenheim B.,
    5. Göbel U. B.
    Treponema maltophilum sp. nov., a small oral spirochete isolated from human periodontal lesions. Int. J. Syst. Bacteriol. 46 1996 745 752
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I
L. V. Stamm, H. L. Bergen, K. A. Shangraw
Antimicrobial Agents and Chemotherapy Oct 2001, 45 (10) 2973-2974; DOI: 10.1128/AAC.45.10.2973-2974.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I
L. V. Stamm, H. L. Bergen, K. A. Shangraw
Antimicrobial Agents and Chemotherapy Oct 2001, 45 (10) 2973-2974; DOI: 10.1128/AAC.45.10.2973-2974.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA-Directed RNA Polymerases
Drug Resistance, Bacterial
Treponema

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596